| |
| |
| Exchange: |
Nasdaq National Market |
| Security
Type: |
Common |
| Shares
Out: |
54,644,000 |
| Market
Cap: |
N/A |
| Last
Volume: |
855,637 |
Avg
Vol: |
396,920 |
| 52
Week Range: |
$17.95 - $17.95 |
|
| Level
I Sector: |
Health Care |
| Level
II Sector: |
Health Services |
| Level
III Sector: |
Medical Appliances & Equipment |
|
Member Indexes:
|
| |
NASDAQ COMPOSITE |
|
NASDAQ NNM COMPOSITE |
|
Rankings:
|
|
| Insider 3 Months : - |
| Insider 6 Months : - |
| Insider 3/6 Months : - |
|
| Guru Rank Number : - |
| Guru Rank Value : - |
| Guru Occurances : - |
|
|
|
|
|
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
|
3m +/-:
|
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
|
Actions:
|
|
|
| B |
Buy |
| S |
Sell |
| OE |
Option
Exercised |
| A |
Acquired |
| D |
Disposed |
| AB |
Automatic
Buy |
| AS |
Automatic
Sell |
| IO |
Initial
Ownership |
|
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
| |
| |
Summary (Direct Transactions Only)  |
3 Months |
6 Months |
12 Months |
24 Months |
| Total Shares Bought |
0 |
0 |
0 |
0 |
| Total Buy Value |
$0 |
$0 |
$0 |
$0 |
| Total People Bought |
0 |
0 |
0 |
0 |
| Total Buy Transactions |
0 |
0 |
0 |
0 |
| Total Shares Sold |
0 |
0 |
0 |
0 |
| Total Sell Value |
$0 |
$0 |
$0 |
$0 |
| Total People Sold |
0 |
0 |
0 |
0 |
| Total Sell Transactions |
0 |
0 |
0 |
0 |
| End Date |
2024-02-04 |
2023-11-03 |
2023-05-05 |
2022-05-05 |
|
| Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
  Quinoy Jorge J |
VP, Worldwide Sales & Marketin |
• – – |
2013-02-19 |
4 |
OE |
$0.00 |
$0 |
D/D |
1,267 |
108,765 |
|
- |
|
| Lippoldt Darin |
Sr. Vice President,Sr. Vice Pr |
• – – |
2013-02-19 |
4 |
OE |
$0.00 |
$0 |
D/D |
760 |
2,887 |
|
- |
|
| Flanders Dale |
General ManagerGeneral Manager |
• – – |
2013-02-19 |
4 |
OE |
$0.00 |
$0 |
D/D |
950 |
12,144 |
|
- |
|
| Dahldorf John T |
Chief Financial Officer |
• – – |
2013-02-19 |
4 |
OE |
$0.00 |
$0 |
D/D |
2,066 |
44,890 |
|
- |
|
| Huennekens R Scott |
President & CEO |
• • – |
2013-02-19 |
4 |
GA |
$0.00 |
$0 |
D/D |
9,526 |
63,997 |
|
- |
|
| Lippoldt Darin |
Sr. VP, General Counsel |
• – – |
2013-02-19 |
4 |
AS |
$25.23 |
$7,897 |
D/D |
(313) |
2,127 |
|
- |
|
| Flanders Dale |
General Manager |
• – – |
2013-02-19 |
4 |
AS |
$25.23 |
$13,625 |
D/D |
(540) |
11,194 |
|
- |
|
| Lippoldt Darin |
Sr. VP, General Counsel |
• – – |
2013-02-15 |
4 |
OE |
$0.00 |
$0 |
D/D |
700 |
2,440 |
|
- |
|
| Flanders Dale |
General Manager |
• – – |
2013-02-15 |
4 |
OE |
$0.00 |
$0 |
D/D |
1,675 |
11,734 |
|
- |
|
| Quinoy Jorge J |
VP, Worldwide Sales & Marketin |
• – – |
2013-02-15 |
4 |
OE |
$0.00 |
$0 |
D/D |
3,125 |
107,498 |
|
- |
|
| Sheehan David M |
Chief Operating Officer |
• – – |
2013-02-06 |
4 |
AS |
$24.64 |
$23,532 |
D/D |
(955) |
23,677 |
|
- |
|
| Dahldorf John T |
Chief Financial Officer |
• – – |
2013-02-06 |
4 |
AS |
$24.64 |
$18,013 |
D/D |
(731) |
42,824 |
|
- |
|
| Huennekens R Scott |
President & CEO |
• • – |
2013-02-06 |
4 |
AS |
$24.64 |
$88,634 |
D/D |
(3,597) |
54,471 |
|
- |
|
| Flanders Dale |
General Manager |
• – – |
2013-02-06 |
4 |
AS |
$24.64 |
$33,142 |
D/D |
(1,345) |
10,059 |
|
- |
|
| Lussier Michel E |
Group President, Clinical Aff. |
• – – |
2013-02-06 |
4 |
AS |
$24.75 |
$81,189 |
D/D |
(3,280) |
12,953 |
|
- |
|
| Sheehan David M |
Chief Operating Officer |
• – – |
2013-02-05 |
4 |
OE |
$0.00 |
$0 |
D/D |
3,585 |
24,632 |
|
- |
|
| Dahldorf John T |
Chief Financial Officer |
• – – |
2013-02-05 |
4 |
OE |
$0.00 |
$0 |
D/D |
3,585 |
43,555 |
|
- |
|
| Huennekens R Scott |
President & CEO |
• • – |
2013-02-05 |
4 |
OE |
$0.00 |
$0 |
D/D |
12,500 |
58,068 |
|
- |
|
| Flanders Dale |
General Manager |
• – – |
2013-02-05 |
4 |
OE |
$0.00 |
$0 |
D/D |
3,585 |
11,404 |
|
- |
|
| Quinoy Jorge J |
VP, Worldwide Sales & Marketin |
• – – |
2013-02-05 |
4 |
OE |
$0.00 |
$0 |
D/D |
2,500 |
104,373 |
|
- |
|
| Lussier Michel E |
Group President, Clinical Aff. |
• – – |
2013-02-05 |
4 |
OE |
$0.00 |
$0 |
D/D |
3,585 |
16,233 |
|
- |
|
| Sheehan David M |
Chief Operating Officer |
• – – |
2013-02-05 |
4 |
AS |
$24.78 |
$50,183 |
D/D |
(2,025) |
21,047 |
|
- |
|
| Huennekens R Scott |
President & CEO |
• • – |
2013-02-05 |
4 |
AS |
$24.78 |
$139,099 |
D/D |
(5,613) |
45,568 |
|
- |
|
| Dahldorf John T |
Chief Financial Officer |
• – – |
2013-02-05 |
4 |
AS |
$24.78 |
$78,384 |
D/D |
(3,163) |
39,970 |
|
- |
|
| Quinoy Jorge J |
VP, Worldwide Sales & Marketin |
• – – |
2013-02-05 |
4 |
AS |
$24.81 |
$248,088 |
D/D |
(10,000) |
101,873 |
|
- |
|
722 Records found
|
|
Page 7 of 29 |
|
|
